| 查看: 1328 | 回复: 12 | ||
| 【奖励】 本帖被评价9次，作者海天天意增加金币 7.2 个 | ||
[资源]
Chem. Rev.11.25新鲜上线：Nanomaterials for Theranostics: Recent Advances
|
||
|
Nanomaterials for Theranostics: Recent Advances and Future Challenges Eun-Kyung Lim,†,‡,§ Taekhoon Kim,∥,⊥,§ Soonmyung Paik,#,∇ Seungjoo Haam,○ Yong-Min Huh,*,† and Kwangyeol Lee*,∥ （68页，907篇文献） CONTENTS 1. Introduction A 1.1. What Are the Key Biological Processes Pertinent to Diseases, and How Can These Processes Be Monitored? C 1.2. What Is the Core Advantage of in Vivo Imaging over in Vitro Assays? C 1.3. What Are the Key Challenges That Need To Be Addressed To Overcome the Fundamental Limitations of in Vivo Imaging? C 2. Major Cancer Signaling Pathways and the Concept of Targeted Delivery D 3. Design of Theranostic Nanoparticles F 3.1. Biomedical Payloads F 3.1.1. Imaging F 3.1.2. Therapeutics I 3.2. Carrier M 3.2.1. Polymers N 3.2.2. Lipids N 3.2.3. Dendrimers N 3.2.4. Inorganic Nanocarriers O 3.3. Surface Modifiers O 4. Pharmacokinetic and Pharmacodynamic Properties of Nanomaterial-Based Therapy P 5. Theranostic Nanomaterials R 5.1. Magnetic Nanoparticles R 5.1.1. Magnetic Nanoparticles as Imaging Agents T 5.1.2. Magnetic Nanoparticles as Drug Delivery Vehicles AD 5.1.3. Magnetic Nanoparticles as Hyperthermal Agents AE 5.1.4. Magnetic Nanoparticles as Anticancer Drugs AG 5.2. Quantum Dots (QDs) AH 5.2.1. Strategies for Reduced RES Uptake AI 5.2.2. Anticancer Drug and Other Chemical Drug Delivery AI 5.2.3. Gene Delivery AJ 5.3. Metal Nanoparticles AJ 5.3.1. Metal Nanoparticle as Imaging Agent AK 5.3.2. Metal Nanoparticle as Photothermal Agent AM 5.3.3. Drug Release Triggered by Metal Nanoparticle-Based Hyperthermia AO 5.4. Upconversion Nanoparticles (UCNPs) AS 5.4.1. Imaging Agent AS 5.4.2. Photosensitizer Activator AS 5.5. Silica and Other Inorganic Nanomaterials AT 5.5.1. Silica AT 5.5.2. Calcium Phosphate AV 5.5.3. Apatite AV 5.5.4. Metal Organic Frameworks (MOFs) AV 5.6. Carbon-Based Nanomaterials AW 5.6.1. Carbon Nanomaterials as Carrier AW 5.6.2. Carbon Materials for Photothermal Therapy AY 6. Summary and Outlook AZ Author Information BA Corresponding Authors BA Author Contributions BA Notes BA Biographies BA Acknowledgments BB Abbreviations BB References BC  normal.img-002 (1).jpg |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : Nanomaterials_for_Theranostics-cr300213b.pdf
2014-11-26 14:25:13, 3.69 M
» 猜你喜欢
biomed res int杂志发表但是不被SCIE检索是什么情况
已经有2人回复
-
求助天然药物化学考博真题
已经有0人回复
-
中医学论文润色/翻译怎么收费?
已经有200人回复
-
求助gastroplus 建立PBPK模型--可支付费用
已经有1人回复
-
求贝凡洛尔 犬 药代数据
已经有0人回复
-
改良吸入制剂非临床研究内容
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
3楼2014-11-26 18:10:42
4楼2014-11-26 18:14:16
6楼2014-12-08 20:36:00
12楼2016-10-18 14:55:34
简单回复
w82171742楼
2014-11-26 14:54
回复
五星好评 顶一下，感谢分享！
quan12zf5楼
2014-11-26 23:19
回复
五星好评 顶一下，感谢分享！
sola仰望天空7楼
2015-01-26 21:32
回复
五星好评 顶一下，感谢分享！
zhuangq8楼
2015-07-17 16:56
回复
五星好评 顶一下，感谢分享！
2015-08-03 10:11
回复
五星好评 顶一下，感谢分享！
XJP100710楼
2015-10-14 20:15
回复
五星好评 顶一下，感谢分享！
Jackcd1211楼
2016-10-18 00:01
回复
五星好评 顶一下，感谢分享！
sunshaokai13楼
2017-01-19 20:13
回复
五星好评 顶一下，感谢分享！
